Publicaciones en colaboración con investigadores/as de University of Copenhagen (33)

2024

  1. Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

    Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892

2023

  1. ATXN3 controls DNA replication and transcription by regulating chromatin structure

    Nucleic acids research, Vol. 51, Núm. 11, pp. 5396-5413

  2. Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocol

    Basic and Clinical Pharmacology and Toxicology, Vol. 133, Núm. 3, pp. 237-253

  3. Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    The Lancet Regional Health - Europe, Vol. 33

  4. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation

    Nature Communications, Vol. 14, Núm. 1

  5. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  6. The genomic history of the indigenous people of the Canary Islands

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Effect of naturally-occurring mutations on the stability and function of cancer-associated NQO1: Comparison of experiments and computation

    Frontiers in Molecular Biosciences, Vol. 9

  2. Estimating Renal Function Following Lung Transplantation

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  3. Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression

    Communications Biology, Vol. 5, Núm. 1

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation

    Transplant International, Vol. 34, Núm. 8, pp. 1341-1359

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update

    Nephron, Vol. 145, Núm. 4, pp. 317-329

  4. Topoisomerase II deficiency leads to a postreplicative structural shift in all Saccharomyces cerevisiae chromosomes

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization (The Pharmacogenomics Journal, (2020), 20, 5, (621-628), 10.1038/s41397-019-0140-y)

    Pharmacogenomics Journal

  2. Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation

    Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 621-628

2019

  1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    The Lancet, Vol. 393, Núm. 10184, pp. 1937-1947

  2. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 208-230

  3. The p97–Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8

    EMBO Journal, Vol. 38, Núm. 21